BOSTON, Feb. 28, 2024 /PRNewswire/ Today, Ginkgo Bioworks , which is building the leading platform for cell programming and biosecurity, announced the acquisition of key assets of Reverie Labs,.
BOSTON, Feb. 28, 2024 /PRNewswire/ Today, Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, announced the acquisition of key assets of Reverie
Society for Science alumna Anjali Chadha, Kavya Kopparapu, Magan Lewis and Erin Smith spoke with Nicole Small, CEO of LH Capital, Inc. and Lyda Hill Philanthropies, during the Women in STEM panel at Regeneron ISEF 2023.